Curevac names oncologist and drug development expert dr. mehdi shahidi to supervisory board

TÜbingen, germany and boston, ma / accesswire / august 15, 2024 / curevac n.v. (nasdaq:cvac) ("curevac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), today named clinical oncologist mehdi shahidi, m.d.
CVAC Ratings Summary
CVAC Quant Ranking